Virus inactivated dried plasma (Entegrion)

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameVirus inactivated dried plasma (Entegrion)
Drug Alias NameResusix
ClassificationBiologics > Blood components
Mechanisms of ActionCoagulation factor replacements
TargetsCoagulation factor
Therapy Area/IndicationsBlood Coagulation Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEntegrion Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEntegrion Inc
Active IndicationsN/A
Inactive IndicationsBlood Coagulation Disorders

Other Information

ATC CodeN/A
Related LinksN/A